Skip to main content
Top
Gepubliceerd in: Journal of Autism and Developmental Disorders 4/2021

10-07-2020 | Original Paper

Factors Affecting Family Compliance with Genetic Testing of Children Diagnosed with Autism Spectrum Disorder

Auteurs: Yonah Hendel, Gal Meiri, Hagit Flusser, Analya Michaelovski, Ilan Dinstein, Idan Menashe

Gepubliceerd in: Journal of Autism and Developmental Disorders | Uitgave 4/2021

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

There is broad consensus about the importance of post-diagnostic genetic testing for children with ASD. However, the extent of compliance with these tests and the factors affecting compliance have rarely been examined. We surveyed a sample of 114 families with a child with ASD in Israel, where such genetic testing is funded by the government. We found that only one-third of these families completed post-diagnosis genetic testing for their child. The main factor influencing compliance was the doctor′s recommendation (OR 11.6; 95% CI 3.2–42.4; p < 0.001). Furthermore, > 50% of the non-compliant families reported that genetic testing was irrelevant to them. Our findings highlight the importance of providing clear recommendations and explanations regarding the benefits and relevance of post-diagnosis genetic testing for children with ASD.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
go back to reference Baio, J., et al. (2018). Prevalence of autism spectrum disorder among children aged 8 years—Autism and developmental disabilities monitoring network, 11 sites, United States, 2014. Morbidity and Mortality Weekly Report Surveillance Summaries (Washington, DC: 2002), 67, 1–23. https://doi.org/10.15585/mmwr.ss6706a1.CrossRef Baio, J., et al. (2018). Prevalence of autism spectrum disorder among children aged 8 years—Autism and developmental disabilities monitoring network, 11 sites, United States, 2014. Morbidity and Mortality Weekly Report Surveillance Summaries (Washington, DC: 2002), 67, 1–23. https://​doi.​org/​10.​15585/​mmwr.​ss6706a1.CrossRef
go back to reference Guideline, A.N.C. SIGN 145—Assessment, diagnosis and interventions for autism spectrum disorders. Healthcare Improvement Scotland. Guideline, A.N.C. SIGN 145—Assessment, diagnosis and interventions for autism spectrum disorders. Healthcare Improvement Scotland.
go back to reference Israel, Central Bureau of Statistics of Israel. (2008). Characterization and classification of geographical units by the socio-economic level of the population. Environment and Region. Israel, Central Bureau of Statistics of Israel. (2008). Characterization and classification of geographical units by the socio-economic level of the population. Environment and Region.
go back to reference Israel, Ministry of Health. (1995). National Health Insurance Law. Israel, Ministry of Health. (1995). National Health Insurance Law.
go back to reference Israel, Ministry of Health. (2013). Children on the autism spectrum diagnosis. Director General Circular. Israel, Ministry of Health. (2013). Children on the autism spectrum diagnosis. Director General Circular.
go back to reference Kearney, H. M., South, S. T., Wolff, D. J., Lamb, A., Hamosh, A., & Rao, K. W. (2011). American College of Medical Genetics recommendations for the design and performance expectations for clinical genomic copy number microarrays intended for use in the postnatal setting for detection of constitutional abnormalities. Genetics in Medicine, 13, 676–679. https://doi.org/10.1097/GIM.0b013e31822272ac.CrossRefPubMed Kearney, H. M., South, S. T., Wolff, D. J., Lamb, A., Hamosh, A., & Rao, K. W. (2011). American College of Medical Genetics recommendations for the design and performance expectations for clinical genomic copy number microarrays intended for use in the postnatal setting for detection of constitutional abnormalities. Genetics in Medicine, 13, 676–679. https://​doi.​org/​10.​1097/​GIM.​0b013e31822272ac​.CrossRefPubMed
go back to reference Kogan, M. D., et al. (2018). The prevalence of parent-reported autism spectrum disorder among US children. Pediatrics, 142, e20174161.CrossRef Kogan, M. D., et al. (2018). The prevalence of parent-reported autism spectrum disorder among US children. Pediatrics, 142, e20174161.CrossRef
go back to reference Lord, C., et al. (2000). The autism diagnostic observation schedule-generic: A standard measure of social and communication deficits associated with the spectrum of autism. Journal of Autism and Developmental Disorders, 30, 205–223.CrossRef Lord, C., et al. (2000). The autism diagnostic observation schedule-generic: A standard measure of social and communication deficits associated with the spectrum of autism. Journal of Autism and Developmental Disorders, 30, 205–223.CrossRef
Metagegevens
Titel
Factors Affecting Family Compliance with Genetic Testing of Children Diagnosed with Autism Spectrum Disorder
Auteurs
Yonah Hendel
Gal Meiri
Hagit Flusser
Analya Michaelovski
Ilan Dinstein
Idan Menashe
Publicatiedatum
10-07-2020
Uitgeverij
Springer US
Gepubliceerd in
Journal of Autism and Developmental Disorders / Uitgave 4/2021
Print ISSN: 0162-3257
Elektronisch ISSN: 1573-3432
DOI
https://doi.org/10.1007/s10803-020-04589-y

Andere artikelen Uitgave 4/2021

Journal of Autism and Developmental Disorders 4/2021 Naar de uitgave